TY - JOUR AU - Cohen, M. H. AU - Williams, G. AU - Johnson, J. R. AU - Duan, J. AU - Gobburu, J. AU - Rahman, A. AU - Benson, K. AU - Leighton, J. AU - Kim, S. K. AU - Wood, R. PY - 2002 DA - 2002// TI - Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia JO - Clin Cancer Res VL - 8 ID - Cohen2002 ER - TY - JOUR AU - Bjorkholm, M. AU - Ohm, L. AU - Eloranta, S. AU - Derolf, A. AU - Hultcrantz, M. AU - Sjoberg, J. AU - Andersson, T. AU - Hoglund, M. AU - Richter, J. AU - Landgren, O. PY - 2011 DA - 2011// TI - Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008 JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.34.7146 DO - 10.1200/JCO.2011.34.7146 ID - Bjorkholm2011 ER - TY - JOUR AU - Penot, A. AU - Preux, P. M. AU - Guyader, S. AU - Collignon, A. AU - Herry, A. AU - Dufour, V. AU - Monnereau, A. AU - Woronoff, A. S. AU - Troussard, X. AU - Pons, E. PY - 2015 DA - 2015// TI - Incidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980-2009 JO - Leuk Lymphoma VL - 56 UR - https://doi.org/10.3109/10428194.2014.974046 DO - 10.3109/10428194.2014.974046 ID - Penot2015 ER - TY - JOUR AU - Kantarjian, H. AU - Talpaz, M. AU - O’Brien, S. AU - Garcia-Manero, G. AU - Verstovsek, S. AU - Giles, F. AU - Rios, M. B. AU - Shan, J. AU - Letvak, L. AU - Thomas, D. PY - 2004 DA - 2004// TI - High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia JO - Blood VL - 103 UR - https://doi.org/10.1182/blood-2003-11-3800 DO - 10.1182/blood-2003-11-3800 ID - Kantarjian2004 ER - TY - JOUR AU - Kantarjian, H. M. AU - Cortes, J. E. AU - O’Brien, S. AU - Giles, F. AU - Garcia-Manero, G. AU - Faderl, S. AU - Thomas, D. AU - Jeha, S. AU - Rios, M. B. AU - Letvak, L. PY - 2003 DA - 2003// TI - Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-02-0545 DO - 10.1182/blood-2002-02-0545 ID - Kantarjian2003 ER - TY - JOUR AU - Kantarjian, H. AU - Sawyers, C. AU - Hochhaus, A. AU - Guilhot, F. AU - Schiffer, C. AU - Gambacorti-Passerini, C. AU - Niederwieser, D. AU - Resta, D. AU - Capdeville, R. AU - Zoellner, U. PY - 2002 DA - 2002// TI - Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa011573 DO - 10.1056/NEJMoa011573 ID - Kantarjian2002 ER - TY - JOUR AU - Mahon, F. X. AU - Rea, D. AU - Guilhot, J. AU - Guilhot, F. AU - Huguet, F. AU - Nicolini, F. AU - Legros, L. AU - Charbonnier, A. AU - Guerci, A. AU - Varet, B. PY - 2010 DA - 2010// TI - Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(10)70233-3 DO - 10.1016/S1470-2045(10)70233-3 ID - Mahon2010 ER - TY - JOUR AU - Abboud, C. AU - Berman, E. AU - Cohen, A. AU - Cortes, J. AU - DeAngelo, D. AU - Deininger, M. AU - Devine, S. AU - Druker, B. AU - Fathi, A. AU - Jabbour, E. PY - 2013 DA - 2013// TI - The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2013-03-490003 DO - 10.1182/blood-2013-03-490003 ID - Abboud2013 ER - TY - JOUR AU - Conti, R. M. AU - Padula, W. V. AU - Larson, R. A. PY - 2015 DA - 2015// TI - Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU JO - Ann Hematol VL - 94 UR - https://doi.org/10.1007/s00277-015-2319-x DO - 10.1007/s00277-015-2319-x ID - Conti2015 ER - TY - JOUR AU - Romero, M. AU - Chavez, D. AU - Los, R. M. AU - Alvis-Guzman, N. PY - 2014 DA - 2014// TI - Cost-effectiveness of nilotinib, dasatinib and imatinib as first-line treatment for chronic myeloid leukemia in Colombia, 2012 JO - Biomedica VL - 34 UR - https://doi.org/10.7705/biomedica.v34i1.1446 DO - 10.7705/biomedica.v34i1.1446 ID - Romero2014 ER - TY - JOUR AU - Pulte, D. AU - Gondos, A. AU - Redaniel, M. T. AU - Brenner, H. PY - 2011 DA - 2011// TI - Survival of patients with chronic myelocytic leukemia: comparisons of estimates from clinical trial settings and population-based cancer registries JO - Oncologist VL - 16 UR - https://doi.org/10.1634/theoncologist.2010-0393 DO - 10.1634/theoncologist.2010-0393 ID - Pulte2011 ER - TY - JOUR AU - Hoglund, M. AU - Sandin, F. AU - Hellstrom, K. AU - Bjoreman, M. AU - Bjorkholm, M. AU - Brune, M. AU - Dreimane, A. AU - Ekblom, M. AU - Lehmann, S. AU - Ljungman, P. PY - 2013 DA - 2013// TI - Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2013-04-495598 DO - 10.1182/blood-2013-04-495598 ID - Hoglund2013 ER - TY - JOUR AU - Pulte, D. AU - Redaniel, M. T. AU - Bird, J. AU - Jeffreys, M. PY - 2015 DA - 2015// TI - Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century JO - Eur J Haematol VL - 94 UR - https://doi.org/10.1111/ejh.12468 DO - 10.1111/ejh.12468 ID - Pulte2015 ER - TY - JOUR AU - Faber, E. AU - Muzik, J. AU - Koza, V. AU - Demeckova, E. AU - Voglova, J. AU - Demitrovicova, L. AU - Chudej, J. AU - Markuljak, I. AU - Cmunt, E. AU - Kozak, T. PY - 2011 DA - 2011// TI - Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000--a report from the population-based CAMELIA Registry JO - Eur J Haematol VL - 87 UR - https://doi.org/10.1111/j.1600-0609.2011.01637.x DO - 10.1111/j.1600-0609.2011.01637.x ID - Faber2011 ER - TY - JOUR AU - Chihara, D. AU - Ito, H. AU - Matsuda, T. AU - Katanoda, K. AU - Shibata, A. AU - Saika, K. AU - Sobue, T. AU - Matsuo, K. PY - 2012 DA - 2012// TI - Decreasing trend in mortality of chronic myelogenous leukemia patients after introduction of imatinib in Japan and the U.S JO - Oncologist VL - 17 UR - https://doi.org/10.1634/theoncologist.2012-0197 DO - 10.1634/theoncologist.2012-0197 ID - Chihara2012 ER - TY - BOOK AU - Dawson, B. AU - Trapp, R. G. PY - 2001 DA - 2001// TI - Basic & clinical biostatistics PB - McGraw-Hill CY - Monterey ID - Dawson2001 ER - TY - CHAP AU - Boniol, M. AU - Heanue, M. ED - Curado, M. P. ED - Edwards, B. ED - Shin, H. R. ED - Storm, H. ED - Ferlay, J. ED - Heanue, M. ED - Boyle, P. PY - 2008 DA - 2008// TI - Age-standardisation and denominators BT - Cancer incidence in five continents ID - Boniol2008 ER - TY - STD TI - United Nations. World Population Prospects, the 2015 Revision [http://esa.un.org/wpp/Excel-Data/population.htm] UR - http://esa.un.org/wpp/Excel-Data/population.htm ID - ref18 ER - TY - JOUR AU - Dickman, P. W. AU - Sloggett, A. AU - Hills, M. AU - Hakulinen, T. PY - 2004 DA - 2004// TI - Regression models for relative survival JO - Stat Med VL - 23 UR - https://doi.org/10.1002/sim.1597 DO - 10.1002/sim.1597 ID - Dickman2004 ER - TY - JOUR AU - Kaplan, E. L. AU - Meier, P. PY - 1958 DA - 1958// TI - Nonparametric Estimation from Incomplete Observations JO - J Am Stat Assoc VL - 53 UR - https://doi.org/10.1080/01621459.1958.10501452 DO - 10.1080/01621459.1958.10501452 ID - Kaplan1958 ER - TY - CHAP AU - Ederer, F. AU - Heise, H. PY - 1959 DA - 1959// TI - Instructions to IBM 650 programmers in processing survival computations BT - Methodological note ID - Ederer1959 ER - TY - JOUR AU - Hoffmann, V. S. AU - Baccarani, M. AU - Hasford, J. AU - Lindoerfer, D. AU - Burgstaller, S. AU - Sertic, D. AU - Costeas, P. AU - Mayer, J. AU - Indrak, K. AU - Everaus, H. PY - 2015 DA - 2015// TI - The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries JO - Leukemia VL - 29 UR - https://doi.org/10.1038/leu.2015.73 DO - 10.1038/leu.2015.73 ID - Hoffmann2015 ER - TY - JOUR AU - Maynadie, M. AU - Angelis, R. AU - Marcos-Gragera, R. AU - Visser, O. AU - Allemani, C. AU - Tereanu, C. AU - Capocaccia, R. AU - Giacomin, A. AU - Lutz, J. M. AU - Martos, C. PY - 2013 DA - 2013// TI - Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study JO - Haematologica VL - 98 UR - https://doi.org/10.3324/haematol.2012.064014 DO - 10.3324/haematol.2012.064014 ID - Maynadie2013 ER - TY - JOUR AU - Sant, M. AU - Allemani, C. AU - Tereanu, C. AU - Angelis, R. AU - Capocaccia, R. AU - Visser, O. AU - Marcos-Gragera, R. AU - Maynadie, M. AU - Simonetti, A. AU - Lutz, J. M. PY - 2010 DA - 2010// TI - Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2010-05-282632 DO - 10.1182/blood-2010-05-282632 ID - Sant2010 ER - TY - JOUR AU - Smith, A. AU - Howell, D. AU - Patmore, R. AU - Jack, A. AU - Roman, E. PY - 2011 DA - 2011// TI - Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network JO - Br J Cancer VL - 105 UR - https://doi.org/10.1038/bjc.2011.450 DO - 10.1038/bjc.2011.450 ID - Smith2011 ER - TY - JOUR AU - Chen, Y. AU - Wang, H. AU - Kantarjian, H. AU - Cortes, J. PY - 2013 DA - 2013// TI - Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009 JO - Leuk Lymphoma VL - 54 UR - https://doi.org/10.3109/10428194.2012.745525 DO - 10.3109/10428194.2012.745525 ID - Chen2013 ER - TY - STD TI - Chronic Myeloid Leukemia [http://seer.cancer.gov/statfacts/html/cmyl.html] UR - http://seer.cancer.gov/statfacts/html/cmyl.html ID - ref27 ER - TY - JOUR AU - Giri, S. AU - Pathak, R. AU - Martin, M. G. AU - Bhatt, V. R. PY - 2015 DA - 2015// TI - Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: a retrospective analysis of the Surveillance, Epidemiology and End Results database JO - Therapeutic advances in hematology VL - 6 UR - https://doi.org/10.1177/2040620715607416 DO - 10.1177/2040620715607416 ID - Giri2015 ER - TY - JOUR AU - Breccia, M. AU - Biondo, F. AU - Latagliata, R. AU - Carmosino, I. AU - Mandelli, F. AU - Alimena, G. PY - 2006 DA - 2006// TI - Identification of risk factors in atypical chronic myeloid leukemia JO - Haematologica VL - 91 ID - Breccia2006 ER - TY - JOUR AU - Druker, B. J. AU - Guilhot, F. AU - O’Brien, S. G. AU - Gathmann, I. AU - Kantarjian, H. AU - Gattermann, N. AU - Deininger, M. W. AU - Silver, R. T. AU - Goldman, J. M. AU - Stone, R. M. PY - 2006 DA - 2006// TI - Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa062867 DO - 10.1056/NEJMoa062867 ID - Druker2006 ER - TY - JOUR AU - Kantarjian, H. AU - O’Brien, S. AU - Jabbour, E. AU - Garcia-Manero, G. AU - Quintas-Cardama, A. AU - Shan, J. AU - Rios, M. B. AU - Ravandi, F. AU - Faderl, S. AU - Kadia, T. PY - 2012 DA - 2012// TI - Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-08-358135 DO - 10.1182/blood-2011-08-358135 ID - Kantarjian2012 ER - TY - STD TI - Pfirrmann M, Saussele S, Baccarani M, Guilhot J, Cervantes F, Ossenkoppele GJ, Lindoerfer D, Hoffmann VS, Castagnetti F, Hehlmann R et al. Survival and Prognosis in Patients with First-Line Imatinib Treatment Under Particular Consideration of Death Due to Chronic Myeloid Leukemia. Blood. 2014;124(21):153. ID - ref32 ER - TY - JOUR AU - Lauseker, M. AU - Hasford, J. AU - Pfirrmann, M. AU - Hehlmann, R. PY - 2014 DA - 2014// TI - The impact of health care settings on survival time of patients with chronic myeloid leukemia JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-11-539742 DO - 10.1182/blood-2013-11-539742 ID - Lauseker2014 ER - TY - JOUR AU - Sant, M. AU - Minicozzi, P. AU - Mounier, M. AU - Anderson, L. A. AU - Brenner, H. AU - Holleczek, B. AU - Marcos-Gragera, R. AU - Maynadie, M. AU - Monnereau, A. AU - Osca-Gelis, G. PY - 2014 DA - 2014// TI - Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70282-7 DO - 10.1016/S1470-2045(14)70282-7 ID - Sant2014 ER - TY - JOUR AU - Osca-Gelis, G. AU - Puig-Vives, M. AU - Saez, M. AU - Gallardo, D. AU - Lloveras, N. AU - Guardia, R. AU - Marcos-Gragera, R. PY - 2015 DA - 2015// TI - Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study JO - Leuk Lymphoma VL - 56 UR - https://doi.org/10.3109/10428194.2014.947610 DO - 10.3109/10428194.2014.947610 ID - Osca-Gelis2015 ER - TY - JOUR AU - Smith, A. G. AU - Painter, D. AU - Howell, D. A. AU - Evans, P. AU - Smith, G. AU - Patmore, R. AU - Jack, A. AU - Roman, E. PY - 2014 DA - 2014// TI - Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort JO - BMJ open VL - 4 UR - https://doi.org/10.1136/bmjopen-2013-004266 DO - 10.1136/bmjopen-2013-004266 ID - Smith2014 ER - TY - STD TI - Trends in incidence and outcome for haematological cancers in England: 2001-2010. In: National cancer intelligence network. 2014. ID - ref37 ER - TY - JOUR AU - Gambacorti-Passerini, C. AU - Antolini, L. AU - Mahon, F. X. AU - Guilhot, F. AU - Deininger, M. AU - Fava, C. AU - Nagler, A. AU - Della Casa, C. M. AU - Morra, E. AU - Abruzzese, E. PY - 2011 DA - 2011// TI - Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib JO - J Natl Cancer Inst VL - 103 UR - https://doi.org/10.1093/jnci/djr060 DO - 10.1093/jnci/djr060 ID - Gambacorti-Passerini2011 ER - TY - JOUR AU - Schellings, M. W. AU - Baumann, M. AU - Leeuwen, R. E. AU - Duisters, R. F. AU - Janssen, S. H. AU - Schroen, B. AU - Peutz-Kootstra, C. J. AU - Heymans, S. AU - Pinto, Y. M. PY - 2006 DA - 2006// TI - Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats JO - Hypertension VL - 47 UR - https://doi.org/10.1161/01.HYP.0000202487.68969.f7 DO - 10.1161/01.HYP.0000202487.68969.f7 ID - Schellings2006 ER - TY - JOUR AU - Kerkela, R. AU - Grazette, L. AU - Yacobi, R. AU - Iliescu, C. AU - Patten, R. AU - Beahm, C. AU - Walters, B. AU - Shevtsov, S. AU - Pesant, S. AU - Clubb, F. J. PY - 2006 DA - 2006// TI - Cardiotoxicity of the cancer therapeutic agent imatinib mesylate JO - Nat Med VL - 12 UR - https://doi.org/10.1038/nm1446 DO - 10.1038/nm1446 ID - Kerkela2006 ER - TY - STD TI - Kurtovic-Kozaric A, Hasic A, Radich JP, Bijedic V, Nefic H, Eminovic I, Kurtovic S, Colakovic F, Kozaric M, Vranic S et al. The reality of cancer treatment in a developing country: the effects of delayed TKI treatment on survival, cytogenetic and molecular responses in chronic myeloid leukaemia patients. British journal of haematology. 2015;172(3):420–7. ID - ref41 ER - TY - JOUR AU - Kim, D. W. AU - Banavali, S. D. AU - Bunworasate, U. AU - Goh, Y. T. AU - Ganly, P. AU - Huang, H. AU - Irving, I. AU - Jootar, S. AU - Goh, H. G. AU - Koh, L. P. PY - 2010 DA - 2010// TI - Chronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy era JO - Leuk Res VL - 34 UR - https://doi.org/10.1016/j.leukres.2010.03.033 DO - 10.1016/j.leukres.2010.03.033 ID - Kim2010 ER - TY - JOUR AU - Wiggins, C. L. AU - Harlan, L. C. AU - Nelson, H. E. AU - Stevens, J. L. AU - Willman, C. L. AU - Libby, E. N. AU - Hromas, R. A. PY - 2010 DA - 2010// TI - Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia JO - Am J Med VL - 123 UR - https://doi.org/10.1016/j.amjmed.2010.03.018 DO - 10.1016/j.amjmed.2010.03.018 ID - Wiggins2010 ER - TY - JOUR AU - Saussele, S. AU - Krauss, M. P. AU - Hehlmann, R. AU - Lauseker, M. AU - Proetel, U. AU - Kalmanti, L. AU - Hanfstein, B. AU - Fabarius, A. AU - Kraemer, D. AU - Berdel, W. E. PY - 2015 DA - 2015// TI - Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV JO - Blood VL - 126 UR - https://doi.org/10.1182/blood-2015-01-617993 DO - 10.1182/blood-2015-01-617993 ID - Saussele2015 ER - TY - JOUR AU - Gugliotta, G. AU - Castagnetti, F. AU - Palandri, F. AU - Breccia, M. AU - Intermesoli, T. AU - Capucci, A. AU - Martino, B. AU - Pregno, P. AU - Rupoli, S. AU - Ferrero, D. PY - 2011 DA - 2011// TI - Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2010-12-324228 DO - 10.1182/blood-2010-12-324228 ID - Gugliotta2011 ER -